Cookie Consent by Privacy Policies website

Media

The Race Is On to Stop Ozempic Muscle Loss

February 8, 2024
View Article

Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That

January 22, 2024
View Article

Is There A Drug To Help You Lose Fat And Gain Muscle Without Exercise?

January 3, 2024
View Article

Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle

November 17, 2023
View Article

These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass

October 22, 2023
View Article

People who use weight loss drugs could be at risk of losing muscle mass

May 3, 2023
View Article

Weight loss drugs can lead to muscle loss, too. Is that a bad thing?

May 20, 2023
View Article

Elevai Biosciences Inc., an Elevai Labs company, is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines.

Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.

Pages
AboutSciencePipelineNews
ContactInvestors
Copyright ©ElevaiLabs.
Privacy policyTerms and Conditions